Related Experiment Video
Updated: Oct 27, 2025

Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
Serial ASPECTS in the DAWN Trial: Infarct Evolution and Clinical Impact
David S Liebeskind1, Hamidreza Saber1, Parita Bhuva2
1Neurovascular Imaging Research Core, UCLA, Los Angeles, CA (D.S.L., H.S.).
In late stroke thrombectomy, baseline Alberta Stroke Program Early CT Score (ASPECTS) and its 24-hour evolution are influenced by factors like age and glucose. Higher 24-hour ASPECTS, particularly after endovascular treatment, predicts better clinical outcomes.
Area of Science:
- Neurology
- Radiology
- Stroke Medicine
Background:
- The Alberta Stroke Program Early CT Score (ASPECTS) is crucial for assessing ischemic stroke severity.
- Understanding how baseline ischemia and its evolution impact ASPECTS in late thrombectomy is vital for treatment decisions.
- The DAWN trial provides a unique dataset to analyze these factors in patients undergoing neurointervention.
Purpose of the Study:
- To analyze predictors of serial ASPECTS and clinical outcomes in patients from the DAWN trial.
- To investigate the impact of baseline ischemia and 24-hour infarct evolution on ASPECTS in late thrombectomy.
- To determine the relationship between ASPECTS, treatment, and clinical outcomes in acute ischemic stroke.
Main Methods:
- ASPECTS were independently scored at baseline and 24 hours by the DAWN Imaging Core Laboratory.
- Descriptive statistics characterized ASPECTS changes over 24 hours using computed tomography/magnetic resonance imaging.
- Multivariable logistic regression identified predictors of baseline and 24-hour ASPECTS, and clinical outcomes.
Main Results:
- Older age and dyslipidemia were associated with higher baseline ASPECTS.
- Endovascular treatment, lower baseline NIHSS, and controlled glucose (<150 mg/dL) predicted higher 24-hour ASPECTS.
- Higher 24-hour ASPECTS was a significant predictor of good clinical outcome (90-day mRS 0-2).
- Elevated baseline glucose and internal carotid artery occlusion predicted significant infarct evolution (ASPECTS decrease ≥4).
- ASPECTS change was significantly influenced by treatment arm, with more patients in the endovascular arm showing no ASPECTS change.
Conclusions:
- Patients in the DAWN trial with small infarct cores exhibited a wide range of baseline ASPECTS.
- Twenty-four-hour ASPECTS, significantly influenced by endovascular therapy, effectively predicted good clinical outcomes.
- Baseline glucose levels and lesion location are important factors in stroke evolution and ASPECTS changes.
More Related Videos
09:59A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
08:41Lateral Chronic Cranial Window Preparation Enables In Vivo Observation Following Distal Middle Cerebral Artery Occlusion in Mice
Published on: December 29, 2016
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome I: Introduction